01/27/2026
Lung cancer screening plays an important role in saving lives through early detection.
In a recent Oncology News Central article, Dr. Charles B. Simone II, Chief Medical Officer at the New York Proton Center, joined leaders from national medical societies in reinforcing the value of low-dose CT lung cancer screening when guided by high-quality evidence.
Dr. Simone explains that accurate interpretation of screening data is essential, as early detection allows more patients to be diagnosed at a stage when treatment may be most effective. Clear, evidence-based communication helps patients and clinicians make informed decisions about preventive care.
Read the full article here:
Three prominent medical societies are pushing back against what they describe as misleading claims about the risks of lung cancer screening, which they say could hinder screening uptake and lead to advanced and harder-to-treat disease.